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Non-Hodgkin lymphoma (NHL) of the B-cell type is the 
second most common neoplasm in patients with human 
immunodeficiency virus (HIV) infection after Kaposi sar- 
coma (KS). The majority of cases of NHL in patients with 
acquired immunodeficiency syndrome (AIDS) involve 
extranodal sites; most frequently the gastrointestinal tract 
(GIT) and the central nervous system (CNS).’ Hepatic 
NHL in patients with AIDS was first described by Reichert 
et al in 1983 in an autopsy series2 It usually presents 
with multiple large hepatic masses and involvement of 
other abdominal organs or lymph nodes3 The authors 
present a case of primary hepatic NHL in a patient with 
AIDS, presenting with innumerable small intrahepatic 
masses without the involvement of any other organs. 
CASE REPORT 
A 32-year-old white homosexual man presented with a 2- 
week history of fever, night sweats, weight loss, and jaun- 
dice. He had recently been found to be infected with HIV 
and had been started on zidovudine, lamivudine, indi- 
navir, and prophylactic trimethoprim-sulfamethoxazole. 
He was not a smoker, never used injection drugs, and 
drank alcohol on weekends only He had no pets or sig- 
nificant travel history On admission, his temperature was 
38.1”C, pulse was 100 per minute, blood pressure was 
loo/60 mmHg, and respiratory rate was 16 per minute. 
He was jaundiced, and the liver was enlarged 5 cm below 
the costal margin, nontender, with a sharp border and 
smooth surface. Spleen and peripheral lymph nodes were 
not palpable, and the remainder of the physical exami- 
nation was unremarkable. 
The leukocyte count was 4.0 K&L with relative lym- 
phopenia (12.1%), hemoglobin was 9.7 g/dL, platelet 
count was 186 K&L, lactate dehydrogenase was 435 U/L, 
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aspartate aminotransferase was 370 U/L, alanine amino- 
transferase was 4 12 U/L, gamma-glutamyl transpeptidase 
was 146 U/L, alkaline phosphatase was 259 U/L, total 
bilirubin was 3.7 mg/dL, prothrombin time was 14.0 sec- 
onds, CD4+ T-lymphocyte count was 96/mm3 (16%) HIV 
viral load was 349,000 copies/ml, and chest roentgeno- 
gram was normal. Computerized tomographic (CT) scan 
of the abdomen and pelvis showed hepatomegaly with 
innumerable centimeter to subcentimeter hypodense 
lesions diffusely involving both lobes, with no calciflca- 
tion or intrahepatic biliary dilatation (Figure 1). There 
were no enlarged intra-abdominal or retroperitoneal 
lymph nodes; the visualized bowel was unremarkable; 
and no ascitic fluid was present. 
The patient’s symptoms had anteceded any medica- 
tion use, so a drug-related illness was thought to be 
unlikely Further testing revealed positive hepatitis B core 
and surface antibodies, with negative hepatitis B surface 
antigen and hepatitis C antibody. Fungal serology anti- 
body panel for Histoplasma, Coccidioides, Blastomyces, 
and Aspergillus was negative, as were Histoplasma uri- 
nary antigen and serum cryptococcal antigen. Bartonella 
IgG and IgM, Toxoplasma IgG and IgM, and rapid plasma 
reagin test also were negative. Fungal and mycobacterial 
blood cultures were obtained. Cytomegalovirus (CMV) 
Figure 1. Abdominal CT scan with oral and intravenous contrast show- 
ing multiple, small, hypodense hepatic lesions. 
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DNA detection by hybrid capture assay @gene, BeltsviIle, 
MD) in blood was positive, and therapy with intravenous 
ganciclovir was initiated. 
Because of concerns of possible hepatic oppor- 
tunistic infection (OI) or neoplasm, a percutaneous liver 
biopsy was obtained. It showed a high grade, diffuse, 
small noncleaved cell type, non-Hodgkin lymphoma 
(Burkitt’s lymphoma by the revised American-European 
lymphoma classification). Immunocytochemical staining 
showed lymphoid cells to be positive for CD45RB and 
CD20, and negative for CD3, CDlO, and Epstein-Barr virus 
(EBV) RNA, with the majority of cells staining negative for 
kappa and lambda chains. No viral inclusions suggestive 
of CMV hepatitis were seen. Chest CT scan and brain 
magnetic resonance imaging (MRI) were unremarkable. 
Bone marrow biopsy was normocellular, without evi- 
dence of lymphoma or granulomas, and bronchoalveolar 
lavage fluid as well as the cerebrospinal fluid (CSF) cytolo- 
gies were negative for malignant cells. Blood, CSF, bone 
marrow biopsy, and liver biopsy cultures for fungi and 
mycobacteria eventually returned negative. The patient 
and his family wanted to attempt chemotherapy, so he 
was initiated on a low-dose m-BACOD protocol (metho- 
trexate, bleomycin, doxorubicin, cyclophosphamide, vin- 
cristine, and dexamethasone). One week later, he 
developed tumor lysis syndrome and adult respiratory 
distress syndrome. According to his prior wishes and his 
family’s request, cardiopulmonary resuscitation was not 
attempted, and the patient died 5 days later. Complete 
autopsy was done, which confirmed the diagnosis of 
hepatic NHL, with absence of involvement of all other 
organs and lymphoid tissue. 
DISCUSSION 
In patients with AIDS, neoplasia represents the most 
common cause of hepatic mass lesions, with KS being 
far more common than NHL. In more than 90% of 
patients with hepatic lesions, the abdominal CT scan 
shows evidence of lymphomatous involvement of other 
abdominal organs or lymph nodes.4 Primary hepatic 
lymphoma in patients with AIDS is rare; only 15 such 
cases have been described in the literature.3 Most of 
these cases presented with multiple hypodense mass 
lesions larger than those seen with 01 or KS. Their 
median survival was between 4 and 6 months. Combi- 
nation chemotherapy remains the best available option, 
with a response rate of approximately 50%, and 25% of 
responders relapsing within 6 months.5 Antiretroviral 
agents should be continued during chemotherapy as 
tolerated.6 
This case illustrates the difficulty in differentiating 
NHL from 01 in patients with AIDS. The unusual radio- 
logic appearance of hepatic NHL in this case is important 
to recognize. 
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